SCYX Return on Tangible Equity | SCYNEXIS, Inc.

SCYNEXIS, Inc. (SCYX) Return on Tangible Equity

2026-06-30: Return Tang Equity -15.29%.
2026-03-31: Return Tang Equity -59.35%.
2025-12-31: Return Tang Equity -17.44%.
2025-09-30: Return Tang Equity -69.45%.

Complete source-backed return tang equity history.

Available history: 2013-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-15.29%
2026-03-31	-59.35%
2025-12-31	-17.44%
2025-09-30	-69.45%
2025-06-30	-43.89%
2025-03-31	-53.61%
2024-12-31	-38.65%
2024-09-30	-62.26%
2024-06-30	-58.59%
2024-03-31	136.74%
2023-12-31	91.88%
2023-09-30	78.83%
2023-06-30	47.88%
2023-03-31	300.88%
2022-12-31	-2223.33%
2022-09-30	-480.55%
2022-06-30	-109.50%
2022-03-31	-88.83%
2021-12-31	-81.75%
2021-09-30	-124.53%
2021-06-30	-140.45%
2021-03-31	-207.16%
2020-12-31	-246.91%
2020-09-30	-281.77%
2020-06-30	-565.01%
2020-03-31	-585.65%
2019-12-31	-416.52%
2019-09-30	-607.36%
2019-06-30	-278.97%
2019-03-31	-276.89%
2018-12-31	-39.92%
2018-09-30	-78.91%
2018-06-30	-115.81%
2018-03-31	-65.66%
2017-12-31	-117.04%
2017-09-30	-76.72%
2017-06-30	-75.01%
2017-03-31	-82.53%
2016-12-31	-86.13%
2016-09-30	-105.28%
2016-06-30	-73.06%
2016-03-31	-95.38%
2015-12-31	-77.77%
2015-09-30	-54.65%
2015-06-30	-40.09%
2015-03-31	-40.20%
2014-12-31	-12.66%
2014-09-30	-63.33%
2014-06-30	-58.45%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-17.44%
2024-12-31	-38.65%
2023-12-31	91.88%
2022-12-31	-2223.33%
2021-12-31	-81.75%
2020-12-31	-246.91%
2019-12-31	-416.52%
2018-12-31	-39.93%
2017-12-31	-117.05%
2016-12-31	-86.13%
2015-12-31	-77.77%
2014-12-31	-12.66%
2013-12-31	28.18%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
PDS Biotechnology Corp (PDSB)	United States	$0.045B
Grace Therapeutics, Inc. (GRCE)		$0.046B	-1.83
VERU INC. (VERU)	United States	$0.043B	-3.93
Werewolf Therapeutics, Inc. (HOWL)	United States	$0.047B
Kairos Pharma, LTD. (KAPA)	United States	$0.041B
Dogwood Therapeutics, Inc. (DWTX)	United States	$0.049B
Lite Strategy, Inc. (LITS)	United States	$0.049B
Incannex Healthcare Inc. (IXHL)		$0.040B	-22.32
Elicio Therapeutics, Inc. (ELTX)	United States	$0.049B
Karyopharm Therapeutics Inc. (KPTI)	United States	$0.039B	-0.98